Bain & Company is taking a minority stake in Kohlberg-backed life sciences commercialization firm Trinity Life Sciences as part of a new strategic partnership, the firm tells Axios exclusively.
Why it matters: The investment underscores demand in life sciences for outside resources to support innovation and strategic playbooks, while navigating a complex regulatory and deal environment.
